Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000174

EVP, Chief Development Officer sold 10,000 shares at $42.86 ($428,593)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Geary Richard S EVP, Chief Development Officer 2025-08-05 Sale 10b5-1 −10,000 $42.86 $428,593 89,492 D: show line 1 in the form
Open-market sales · 10,000 sh · avg $42.86 · $428,593
Loading xslF345X05/edgardoc.xml…